µTASWako™ i30


µTASWako i30 (Micro Total Analysis System) is the worldwide unique system for the automated measurement of the biomarkers AFP-L3 and DCP.

Both, AFP-L3 (lectin-reactive alpha-fetoprotein) and DCP (des-gamma-carboxy prothrombin), have been shown to be specific for risk assessment of the main primary liver cancer hepatocellular carcinoma (HCC.)

µTASWako i30 integrates immunoassay steps in disposable, microfluidic microchips. Single tests can be performed in only 9 minutes.

Key Features

  • For in vitro diagnostic use
  • Electrokinetic Analyte Transport Assay (EATA)
  • High sensitive fluorescence detection
  • Available analytes: AFP/AFP-L3 and DCP
  • Assay precision less than 3% CV for AFP-L3
  • Throughput: 25 tests/h


Width: 520 mm
Depth: 600 mm
Height: 550 mm
Weight: 71 kg



Store µTASWako™ Chip Cassette and µTASWako™ Wash Solution at 2-35° C.

Safety information

Health Hazard